Facebook
X
LinkedIn
Forward
0618_PAMF_Fatty Liver Grand Rounds_Live
Description:
Fatty liver disease has long been a widespread yet under-addressed condition, with limited treatment options beyond weight loss recommendations. However, recent advancements in diagnostics and newly approved medications have transformed the landscape of care. Despite these developments, a significant gap remains in the understanding of how to appropriately evaluate and manage these patients, both at the primary care and GI levels. This presentation will provide an overview of the latest epidemiological trends, pathophysiology, and newly released guidelines from the past year. It will also cover essential aspects of the referral process, diagnostic testing, and emerging treatment options. Additionally, we will discuss the impact of social determinants of health (SDOH) and implicit bias in the management of fatty liver disease.
Target Audience
Physicians (MD or DO)
Learning Objectives
After completing this activity learners will be able to:
1. Review the latest guidelines and evidence-based strategies for the diagnosis, risk stratification, and treatment of fatty liver disease, including the use of emerging pharmacologic therapies.
2. Integrate best practices for timely referrals and multidisciplinary collaboration between primary care, gastroenterology, and hepatology to optimize patient outcomes.
Reference for Self-Directed Learning in Compliance with Assembly Bills 1195 & 241- Providing Culturally Appropriate Care which is Free of Implicit Biases:
Implicit Bias Reference
Westbury S, Oyebode O, van Rens T, Barber TM. Obesity Stigma: Causes, Consequences, and Potential Solutions. Curr Obes Rep. 2023 Mar;12(1):10-23. doi: 10.1007/s13679-023-00495-3. Epub 2023 Feb 14. PMID: 36781624; PMCID: PMC9985585.
SDOH
Abu-Rumaileh M, Dhoop S, Pace J, Qapaja T, Martinez ME, Tincopa M, Loomba R. Social Determinants of Health Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-analysis. Am J Gastroenterol. 2025 Mar 17. doi: 10.14309/ajg.0000000000003421. Epub ahead of print. PMID: 40094308.
Dr. Erick Chan, the Speaker for this educational delivery, has stock in Gilead and Merck Pharmaceuticals. This ineligible relationship was not deemed relevant to the content of the talk and a speaker attestation form was completed.
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Kerri Maya, PhD(c), MSL, RN, NPD-BC
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.00 AMA PRA Category 1 Credits™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Note to Other Disciplines: AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
Physician Credit
Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Non-Physician Participation Credit
Sutter Health designates this Live activity for a maximum of 1.00 Non-Physician Participation Credit. Non-Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.